Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma.
Xin ZhengLuyu YangXiaotian ShenJunjie PanYiran ChenJixuan ChenHao WangJiaqi MengZhenchao ChenSunzhe XieYitong LiBolun ZhuWenwei ZhuLunxiu QinLu LuPublished in: Journal for immunotherapy of cancer (2024)
can enhance CTLs function and improve the efficacy of ICIs.